VALIANT LABORATORIES
Back to All Ratios
|
VALIANT LABORATORIES Last 5 Year Working Capital/Sales History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
Working Capital/Sales(x) | 0.93 | 3.34 |
What is the latest Working Capital/Sales ratio of VALIANT LABORATORIES ?
Year | Working Capital/Sales |
---|---|
Mar2024 | 0.93 |
Mar2023 | 3.34 |
How is Working Capital/Sales of VALIANT LABORATORIES Trending?
Years | Working Capital/Sales | % Change | |
---|---|---|---|
Mar2024 | 0.93 | -72.16 | |
Mar2023 | 3.34 | - |
Other Financial Ratios of VALIANT LABORATORIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Working Capital/Sales ratio of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹498.5 Cr | -1% | -12.3% | -24.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹389,172.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,248.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹122,835.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,869.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -1% |
-12.3% |
-24.7% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses